Although we are not pursuing a gene therapy in the current manuscript, we found that TSC1 replenishment along with Rapamycin further decreased proliferation and growth in TSC1-deficient tumors (Figure 6C–E), suggesting an effective strategy for TSC patients with the combinational therapy. Here, TSC1 is linked to tuberous sclerosis.